GeneDx Holdings (WGS) Shares Outstanding (2020 - 2026)

GeneDx Holdings (WGS) has reported Shares Outstanding (Entity) for 7 consecutive years, with $29.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 3.98% year-over-year to $29.7 million; the TTM figure through Mar 2026 stood at $29.7 million (up 3.98% YoY), while the FY2025 annual figure was $29.2 million, up 4.39% from the prior year.
• Shares Outstanding (Entity) improved to $29.7 million in Q1 2026 per WGS's latest filing, from $29.2 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $29.7 million in Q1 2026 and bottomed at $7.4 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $23.1 million across 5 years, with a median of $26.1 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 2714.22% — and 2026, when it grew 3.98%.
• GeneDx Holdings' Shares Outstanding (Entity) stood at $11.8 million in 2022, then jumped by 120.66% to $26.0 million in 2023, then gained by 7.84% to $28.0 million in 2024, then advanced by 4.39% to $29.2 million in 2025, then grew by 1.44% to $29.7 million in 2026.
• Business Quant data shows WGS's Shares Outstanding (Entity) at $29.7 million in Q1 2026, $29.2 million in Q4 2025, and $28.9 million in Q3 2025.